These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7574525)

  • 1. The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Ahgren C; Backro K; Bell FW; Cantrell AS; Clemens M; Colacino JM; Deeter JB; Engelhardt JA; Hogberg M; Jaskunas SR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1329-35. PubMed ID: 7574525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
    Bell FW; Cantrell AS; Högberg M; Jaskunas SR; Johansson NG; Jordan CL; Kinnick MD; Lind P; Morin JM; Noréen R
    J Med Chem; 1995 Dec; 38(25):4929-36. PubMed ID: 8523406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
    Ren J; Diprose J; Warren J; Esnouf RM; Bird LE; Ikemizu S; Slater M; Milton J; Balzarini J; Stuart DI; Stammers DK
    J Biol Chem; 2000 Feb; 275(8):5633-9. PubMed ID: 10681546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.
    Cantrell AS; Engelhardt P; Högberg M; Jaskunas SR; Johansson NG; Jordan CL; Kangasmetsä J; Kinnick MD; Lind P; Morin JM; Muesing MA; Noreén R; Oberg B; Pranc P; Sahlberg C; Ternansky RJ; Vasileff RT; Vrang L; West SJ; Zhang H
    J Med Chem; 1996 Oct; 39(21):4261-74. PubMed ID: 8863804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
    Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
    J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase.
    Venkatachalam TK; Sudbeck EA; Mao C; Uckun FM
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2071-4. PubMed ID: 10999473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.
    Campiani G; Aiello F; Fabbrini M; Morelli E; Ramunno A; Armaroli S; Nacci V; Garofalo A; Greco G; Novellino E; Maga G; Spadari S; Bergamini A; Ventura L; Bongiovanni B; Capozzi M; Bolacchi F; Marini S; Coletta M; Guiso G; Caccia S
    J Med Chem; 2001 Feb; 44(3):305-15. PubMed ID: 11462972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mao C; Vig R; Venkatachalam TK; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2213-8. PubMed ID: 9873515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Sahlberg C; Noréen R; Engelhardt P; Högberg M; Kangasmetsä J; Vrang L; Zhang H
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1511-6. PubMed ID: 9873380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor.
    Isaka Y; Sato A; Kawauchi S; Suyama A; Miki S; Hayami M; Fujiwara T
    Microbiol Immunol; 1998; 42(3):195-202. PubMed ID: 9570285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Maass G; Immendoerfer U; Koenig B; Leser U; Mueller B; Goody R; Pfaff E
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2612-7. PubMed ID: 7509144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
    Buckheit RW; White EL; Fliakas-Boltz V; Russell J; Stup TL; Kinjerski TL; Osterling MC; Weigand A; Bader JP
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1827-34. PubMed ID: 10428899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
    Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
    J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
    Larder BA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2664-9. PubMed ID: 1282792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
    Venkatachalam TK; Mao C; Uckun FM
    Biochem Pharmacol; 2004 May; 67(10):1933-46. PubMed ID: 15130770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.